COVID-19 Action Plan: Deliver Telehealth Services Through CancerIQ

We've been amazed to see teams across the country pulling together to take their cancer genetics programs virtual during these challenging times. To show our support, we commit to:

• Share best practices from CancerIQ clients already offering telegenetics. Many of our customers have been doing this for years. We will make it as easy as possible for providers to learn from each other through user group chats and blog posts. 
• Expedite integrations with telehealth partners and labs to create a seamless provider and patient experience. We are already integrated with multiple testing labs and telehealth partners willing to help us offer an end-to-end solution. This means we are prepared to quickly integrate with existing or new partners. 
• Offer CancerIQ for 90 days for programs seeking an immediate solution to continue to care for patients during this time. We know caring for your patients who are at high-risk or who have cancer can’t wait, but as many patients as possible need to stay home and stay safe. We are here to help providers overcome challenges, not to pose a new one. 

The national emergency has spurred stakeholders to lower barriers previously blocking widespread use of telehealth tools. The Centers for Medicare and Medicaid Services will now (temporarily) pay clinicians who provide telehealth services to Medicare and Medicaid beneficiaries. Private insurers have followed suit. 

We are here to support you and your patients today. And we’re ready to work with you to create a new, better model of care for tomorrow.

If you are an existing CancerIQ client and want to learn more, contact Haibo Lu, VP of Product and Customer Success.

If you are a provider and would like to access our 90-day offer, contact Kelly Hall, VP of Commercial Strategy

If you are a lab interested in partnering with CancerIQ, contact Mike Rocks, Director of Channel Partnerships.